跳至主要内容
临床试验/NCT06327516
NCT06327516招募中不适用

Lysophosphatidylglycerol in Asthma Pathogenesis

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
1
主要终点
lipidomics

研究概览

简要总结

The study aims to investigate the relationship between the small molecule metabolite lysophosphatidylglycerol and asthma clinical features and explore its involvement in asthma pathogenesis.

详细描述

This study screened LPG as a asthma marker by performing metabolomics of the included asthma patients and normal controls, explored the relationship between LPG and clinical features of asthma (including acute exacerbation, asthma control state, asthma treatment steps,lung function, and inflammatory signals including eosinophils, FeNO and total IgE), and further performed in vitro tests to investigate the specific mechanism of LPG's involvement in asthma inflammation through its influence on Treg function.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinical diagnosis of asthma.

排除标准

  • Combined with chronic obstructive pulmonary disease, bronchiectasis, pneumonia, obstructive sleep apnea hypopnea syndrome, malignant tumor
  • Combined with acute and chronic respiratory failure
  • Combined with severe cardiovascular disease
  • Pregnant woman.

结局指标

主要结局

lipidomics

时间窗: when enrolled

collect blood for lipidomic analysis and in vitro assays on Day1

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验